X-40580842-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000436783.6(ATP6AP2):c.-111+1095C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00345 in 488,501 control chromosomes in the GnomAD database, including 22 homozygotes. There are 427 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0099 ( 13 hom., 298 hem., cov: 25)
Exomes 𝑓: 0.0015 ( 9 hom. 129 hem. )
Consequence
ATP6AP2
ENST00000436783.6 intron
ENST00000436783.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.332
Genes affected
ATP6AP2 (HGNC:18305): (ATPase H+ transporting accessory protein 2) This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-40580842-C-T is Benign according to our data. Variant chrX-40580842-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 677652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00987 (1116/113117) while in subpopulation AFR AF= 0.0341 (1062/31184). AF 95% confidence interval is 0.0324. There are 13 homozygotes in gnomad4. There are 298 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP6AP2 | ENST00000436783.6 | c.-111+1095C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00988 AC: 1117AN: 113064Hom.: 13 Cov.: 25 AF XY: 0.00846 AC XY: 298AN XY: 35206
GnomAD3 genomes
AF:
AC:
1117
AN:
113064
Hom.:
Cov.:
25
AF XY:
AC XY:
298
AN XY:
35206
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00151 AC: 568AN: 375384Hom.: 9 Cov.: 4 AF XY: 0.000996 AC XY: 129AN XY: 129478
GnomAD4 exome
AF:
AC:
568
AN:
375384
Hom.:
Cov.:
4
AF XY:
AC XY:
129
AN XY:
129478
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00987 AC: 1116AN: 113117Hom.: 13 Cov.: 25 AF XY: 0.00845 AC XY: 298AN XY: 35269
GnomAD4 genome
AF:
AC:
1116
AN:
113117
Hom.:
Cov.:
25
AF XY:
AC XY:
298
AN XY:
35269
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at